Heartland Group (HGH) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
13 Nov, 2026Opening remarks and agenda
Quorum confirmed; 833 proxies and postal votes representing 383 million shares, or 41% of issued shares, were accepted.
Chair described FY2026 as a year of sustained effort and meaningful progress; agenda covered leadership addresses, FY2026 performance, FY2027 priorities, shareholder discussion and voting.
Financial performance review
FY2026 reported NPAT was $93.2m and underlying NPAT $90.4m; reported ROE rose to 7.3% from 3.2%, underlying ROE was 7.1%, average NIM increased to 3.95% from 3.61%, and impairment expense ratio fell to 0.45% from 1.00%.
NZ bank NPAT was $49.8m; Reverse Mortgage and Rural receivables grew 16.8% and 10.8%, respectively, and NPL ratio improved to 1.92% at 30 June 2026.
Australian lending grew 16.4% to A$2.64bn and NPAT rose 58.2% to A$43m; Reverse Mortgage portfolio grew 19.7% to A$2.37bn in FY2026.
FY2027 reported guidance: NPAT >$102m, ROE ≥7.5%, average NIM >3.88%, OPEX <$212m, CTI ratio <55.7%, and impairment expense ratio <0.32%; September-quarter ROE was 7.6%, NIM 3.92% and CTI 54.7%.
Board and executive committee updates
Greg Tomlinson stood for re-election as a non-independent director; the board and both bank boards supported his re-election.
Establishment Panel endorsed Leanne Lazarus as CEO designate of the proposed merged bank; appointments remain subject to transaction completion and Reserve Bank non-objection.
Proposed merged-bank board comprises existing NZ bank directors and two existing TSB directors, who currently serve on the Establishment Panel.
Latest events from Heartland Group
- Reverse Mortgage growth and improving asset quality supported 1Q earnings and FY targets.HGH
Q1 2027 TU - Merger approved to form a NZD 18.3B nationwide bank with cost synergies and growth focus.HGH
Scheme meeting 2026 - NPAT nearly doubled, asset quality improved, and a major merger is planned for FY27.HGH
H2 2026 - $620M merger forms NZ's seventh largest bank, targeting $34M synergies and EPS growth by 2026.HGH
M&A announcement - Impairment expenses surged amid rising arrears and defaults, with tough conditions expected to continue.HGH
Investor presentation - NPAT surged to $48.8m, with NIM and asset quality gains, and FY2026 guidance reaffirmed.HGH
H1 2026 - FY2025 underlying NPAT met guidance; FY2026 targets $85m+ NPAT and 7%+ ROE.HGH
H2 2025 - Underlying NPAT fell 4.9% below guidance, but strategic growth and digitalisation drive outlook.HGH
H2 2024 - Profit dropped on higher impairments, but reverse mortgage growth and NIM expansion continue.HGH
H1 2025